Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE630.80-4.8 (-0.76 % )
PREV CLOSE (Rs.) 635.60
OPEN PRICE (Rs.) 635.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 62208
TODAY'S LOW / HIGH (Rs.)626.90 644.00
52 WK LOW / HIGH (Rs.)105.56 1025
NSE630.90 -4.65 (-0.73 % )
PREV CLOSE(Rs.) 635.55
OPEN PRICE (Rs.) 631.95
BID PRICE (QTY) 630.90 (1080 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 256470
TODAY'S LOW / HIGH(Rs.) 628.00 644.60
52 WK LOW / HIGH (Rs.)105.25 1026.95

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.08
TTM EPS (Rs.) 28.33
P/E Ratio 22.27
Book Value (Rs.) 89.54
Face Value (Rs.) 10
MCap (Rs. in Mn) 58790.56
Price/Earning (TTM) 18.84
Price/Sales (TTM) 3.14
Price/Book (MRQ) 7.05
PAT Margin (%) 8.30
ROCE (%) 21.29
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone :

Email : NA

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
22Feb02-22-2021$Aarti Drugs gains on the BSE Aarti Drugs gains on the BSE

Aarti Drugs is currently trading at Rs. 645.20, up by 2.60 points or 0.40% from its previous closing of Rs. 642.60 on the BSE.

The scrip opened at Rs. 650.00 and has touched a high and low of Rs. 659.05 and Rs. 644.80 respectively. So far 11219 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1025.00 on 08-Oct-2020 and a 52 week low of Rs. 105.56 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 686.35 and Rs. 638.55 respectively. The current market cap of the company is Rs. 6026.31 crore.

The promoters holding in the company stood at 60.20%, while Institutions and Non-Institutions held 4.74% and 35.07% respectively.

Aarti Drugs has been closed its Wholly Owned Subsidiary Company namely ‘Pinnacle Life Science LLC’. Further, it was not a material subsidiary of the company and did not have any business activity. The wounding-up of this subsidiary will not affect the revenue or business of the company due to nil business activity of this subsidiary.

Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs is currently trading at Rs. 645.20, up by 2.60 poin..
20Feb02-20-2021$Aarti Drugs closes subsidiary company Aarti Drugs closes subsidiar

Aarti Drugs has been closed its Wholly Owned Subsidiary Company namely ‘Pinnacle Life Science LLC’. Further, it was not a material subsidiary of the company and did not have any business activity. The wounding-up of this subsidiary will not affect the revenue or business of the company due to nil business activity of this subsidiary.

Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs has been closed its Wholly Owned Subsidiary Company..
19Feb02-19-2021$ Closure Of Subsidiary Company Closure Of Subsidiary Company
Pursuant to the Regulation 30 of the Listing Regulations, we wish to inform you that Pinnacle Life Science LLC, a Wholly Owned Subsidiary ("subsidiary") of the Company, incorporated at "International Free Zone Authority" (IFZA), Fujairah, UAE, has been closed / wound-up.
Pursuant to the Regulation 30 of the Listing Regulations, we wi..
19Jan01-19-2021$ Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31, 2020 Board Meeting Intimation fo
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Nine months ended December 31, 2020.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board..
30Oct10-30-2020$Aarti Drugs informs about press release Aarti Drugs informs about pr
Aarti Drugs has informed that it has enclosed press release titled, ‘Aarti Drugs Limited: Corporate Updates’ released on 30 October 2020

The above information is a part of company’s filings submitted to BSE. 

Aarti Drugs has informed that it has enclosed press release tit..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit646.61356.7
Gross Profit 851.5 1749.7
Operating Profit 1018.82454.6
Net Sales 472116349.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 8268.85 (1.40%)
M.Cap ( in Cr)
19006.25
Abbott India (BSE)
 14396.65 (0.34%)
M.Cap ( in Cr)
30591.88
Orchid Pharma (BSE)
 885.15 (5.00%)
M.Cap ( in Cr)
3612.86
Alembic Pharma (BSE)
 919.15 (2.38%)
M.Cap ( in Cr)
18067.10
Natural Capsules (BSE)
 117.40 (19.98%)
M.Cap ( in Cr)
73.17
Shareholding Pattern More
PROMOTERS 60.2 %
NON-INSTITUTION 35.07 %
MUTUAL FUNDS/UTI 1.5 %
FI/BANKS/INSURANCE 0.02 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes